ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway.

Bing Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.